2 hours ago MMM of Florida, Inc. is an HMO plan with a Medicare contract. Enrollment in MMM of Florida, Inc. depends on contract renewal. This information is not a complete description of benefits. Contact the plan for more information. Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one ... >> Go To The Portal
You will attest to continuing to meet PCMH criteria and submit data and some documentation. This process is not as involved as initial recognition, but it maintains a practice’s recognition and encourages continuous improvement. When Does Annual Reporting Begin? Your PCMH Annual Reporting date is 30 days prior to your recognition anniversary date.
MMPs are encouraged to work with the individual and the state to assist the individual with regaining Medicaid eligibility during the period of deemed continued eligibility.
, §30.4.1 and §30.4.2 regarding what information must be provided to the individual during the enrollment process).“Fully informed” means that the individual must be provided the applicable rules of the MMP, as described in §30.5 of this guidance and in the state-specific Demonstration Marketing Guidelines.
The state must inform the beneficiary that he or she is a member of the MMP as of the given effective date (as prescribed in §20.1), and must be instructed to continue to use plan services until the disenrollment goes into effect.
Practices must submit data and documentation that cover the 6 PCMH concepts. Practices must meet the minimum number of requirements for each category. The 6 areas include: 1 Patient-Centered Access 2 Team-Based Care 3 Population Health Management 4 Care Management 5 Care Coordination and Care Transitions 6 Performance Measurement and Quality Improvement
As part of maintaining your PCMH recognition, each year your practice will undergo an Annual Reporting process. You will attest to continuing to meet PCMH criteria and submit data and some documentation. This process is not as involved as initial recognition, but it maintains a practice’s recognition and encourages continuous improvement.
Your PCMH Annual Reporting date is 30 days prior to your recognition anniversary date. All Annual Reporting data and documentation must be submitted no later than 30 days prior to your recognition expiration date. Practices that are a part of a multi-site organization share the same Annual Reporting date, unless otherwise requested. The Annual Reporting date is based on the date the first practice achieves recognition.
After you earn recognition, continue to follow the PCMH model and activities. Continue with your quality improvement and performance measurement efforts. This will help during next year’s Annual Reporting.
Practices must submit data and documentation that cover the 6 PCMH concepts. Practices must meet the minimum number of requirements for each category. The 6 areas include:
50.3 - Reinstatements for Invalid Disenrollments ................................................ 79 50.3.1 - Reinstatements for Disenrollment Due to Erroneous Death Indicator or Due to Errone ous Loss of Medicare Part A or Part B, Erroneous Incarceration Information, or Erroneous Unlawful Presence Information ....................................................................................................... 79
While states will have primary responsibility for initiating enrollments , disenrollment , cancellations , and opt-out requests , MMPs will still be responsible for other required data exchanges required by Medicare, including updates to Medicare Part D Low Income Subsidy (LIS) status. Please refer to the CMS Plan Communications User Guide (PCUG) for related information on files that must be exchanged, including:
serves people who are enrolled in both Medicare and Medicaid , also known as dual eligible beneficiaries. The goal of the Initiative is to ensure dual eligible beneficiaries have full access to seamless, high quality integrated health care. Through demonstrations under the capitated financial alignment model, integrated Medicare-Medicaid Plans (MMPs) enter into three-way contracts with CMS and states. The demonstrations also strive to simplify the processes for dual eligible individuals to access the care and services they are entitled to under Medicare and Medicaid programs. This includes providing beneficiaries with a seamless enrollment and disenrollment process as well as clear communication about that process. States play a critical role in this process by working with both CMS and MMPs to ensure that beneficiaries receive information about the demonstrations in clear and timely manner and are appropriately enrolled or disenrolled.
The passive enrollment transactions from the state must be submitted to CMS between 63 and 90 days in advance of the MMP enrollment effective date, but no later than the 63rd day before the MMP enrollment effective date. The beneficiary must receive a passive enrollment notice at least 60 days in advance.
Beginning in April 2018 , CMS started sending the new Medicare cards with the MBI to all Medicare beneficiaries. As of April 1, 2018, CMS is only sending the MBI on enrollment related reports and files. States and MMPs will need to be prepared to process enrollment related transactions using the MBI as of April 2018.
The National MMP Enrollment Guidance has been updated in several key areas since last issued in 2016. The changes provide additional clarity, reduce burden for states and beneficiaries, and incorporates changes in Medicare regulations:
Exhibit 10: Model Notice for CMS Rejection of Enrollment............................ 148 Exhibit 11: Acknowledgement of Request to Cancel Enrollment ..................... 149
ASES do not play a role in determining the eligibility for public employees and pensioners. 1.3 Termination of Eligibility A Medicaid, CHIP, Commonwealth, ELA Employee or Pensioner enrollee who is determined ineligible for MMM Multi Health after a redetermination conducted by the Puerto Rico Medicaid Program will remain eligible for services under MMM Multi Health until the date specified in a negative redetermination decision on the MA-10 issued by the Puerto Rico Medicaid Program. An enrollee who is a public employee or pensioner will remain eligible until disenrolled from MMM Multi Health by the applicable Commonwealth agency. 1.4 The duty to verify eligibility All contracted providers under MMM Multi Health can validate a patient’s eligibility with their enrollee ID. It also provides the patients coverage history and access to print the Certificate of Eligibility. The verification of eligibility warrants that all of its network providers will verify the eligibility of enrollees before the provider provides covered services. This verification of eligibility is a condition of receiving payment. It’s required that the provider verify the enrollee’s eligibility before providing services or making a referral. The systems that support the eligibility verification process are: InnovaMD Access – ( www.innovamd.com ) MSO Provider Call Center Telephones : 787-993-2317 (Metro Area) 1-866-676-6060 (toll free) Monday through Friday, 7:00 a.m. to 7:00 p.m. 2. Enrollment and disenrollment 2.1 Effective date of enrollment With the exception of the example provided below, enrollment, whether chosen or automatic, will be effective the same date as the effective date of eligibility . A newborn
certified pharmacy technicians highly trained to handle clinical interventions and to effectively establish communication with providers involved in charge of health care. The MMM Multi Health Pharmacy Operations team consists on the Clinical Unit and the Rejects Monitoring Unit ● Clinical Pharmacy Unit : responsible for the evaluation and resolution of received coverage determination requests. ● Rejects Monitoring Unit : performs the rejected claims monitoring process, to ensure that claims are not inappropriately rejected at the point of service, based on the MI Salud Formulary of Covered Medications (FMC by its Spanish acronym) and Protocols approved by ASES. MMM Multi Health has a pharmacy drug utilization specialist dedicated to continuously review the Drug Utilization in order to coordinate with the PBM topics to be discussed with medical groups in educational activities through the PBM Academic Detailing program and MMM Multi Health visits to physician offices by its Clinical Practice Consultants (CPC). In these activities topics as polypharmacy and its implications and appropriate use of medicines are discussed. The drug utilization analysis also allow us to establish programs for the optimum treatment of patients conditions such as asthma, depression, diabetes and cholesterol among others, and to identify opportunities for establishing a discipline that allows us to offer our beneficiaries a Pharmacy Benefit Program that assures the quality and effectiveness of the drug therapy. 5.1. Pharmacy Covered Services MMM Multi Health provides pharmacy services, including the following: ● All costs related to prescribed medications for Enrollees, excluding the enrollee’s Copayment where applicable. ● Drugs on the Formulary of Covered Medications of the MI Salud (FMC, for its Spanish acronym) Drugs on the ASES Formulary that are not included in the FMC, but that have been evaluated and approved by ASES
no longer than seventy-two (72) hours after the MMM receives the appeal and makes reasonable efforts to provide oral notice.
The physician’s supporting statement must indicate that the requested prescription drug should be approved based on: o The drug does not have any bioequivalent on the market; and o The drug is clinically indicated because of: o Contra-indication with all drugs that are in the FMC that the Enrollee is already taking, and scientific literature’s indication of the possibility of serious adverse health effects related to the taking the drug; o History of adverse reaction by the Enrollee to some drugs that are on the FMC; o Therapeutic failure of all available alternatives on the FMC o If the drug prescribed is not part of the FMC or the LME at the point of sale the pharmacy will receive the following reject message: ▪ Non- FMC/LME Drug: Exception request required. Validate other alternatives in FMC/LME before proceeding. o If after validation the pharmacy decides to proceed with the evaluation of the prescribed drug, it must contain the following standard information: ▪ Prescription ▪ A supporting statement setting forth the clinical justification and medical necessity for the prescribed medication ▪ Expected duration, as required by the protocol for the medication. o The prescribing physician must provide a written supporting statement based on clinical evidence that the requested prescription drug is medically necessary to treat the member’s disease or medical condition. The physician’s supporting statement must indicate that the requested prescription drug should be approved based on:
6.1 Quality Assessment Performance Improvement Program The Quality Assessment Performance Improvement (QAPI) Program was established specifying quality measurements and performance improvement activities based on clinically sound, nationally developed and accepted criteria standards, and taking into consideration the latest available research in the area of quality assurance. Some of the elements that comprise the QAPI Program will be described in the subsequent sections. 6.2 Advisory Board The Advisory Board is an open discussion forum available to representatives of the Government Health Plan, such as, enrollees, family members, providers, among others, from MMM Multi Health. The stated forum convenes on a quarterly basis. The participants of the Advisory Board shall contribute in the resolution of situations related to the healthcare delivery system, the quality of covered services (for example, physical health and mental health) enrollees rights and responsibilities, resolution of enrollees grievances and appeals, and needs of the groups represented by the participants of the Advisory Board pertaining to the Puerto Rico Medicaid program. MMM Multi Health will promote an equitable representation of the Advisory Board’s participants in terms of race, gender, special populations, and Puerto Rico’s geographic areas in the Government Health Plan. MMM Multi Health will maintain a record of the attendees and of the activities discussed during the Advisory Board meetings. The Advisory Board’s participants shall actively contribute to the discussions; none shall dominate proceedings, in order to foster an inclusive and participative environment. 6.3 Performance Improvement Projects The Performance Improvements Projects (PIPs) are consistent with the statutes of the Federal and State government, the regulations and the requirements of Quality Assessment and Performance Improvement Program pursuant to 42 CFR 438.330. The main purpose of the PIPs is to achieve a favorable and positive effect on health outcomes and satisfaction of the enrollee. The projects are designed to achieve,
The Quality Improvement and Performance Program provides a structure for the delivery of quality care to all enrollees with the primary goal of improving health status or, in instances where the enrollee’s health is not amenable to improvement, maintaining the enrollee's current health status by implementing measures to prevent any further deterioration of his or her health status. Objectives: 1) Measurable compliance and detailed goal setting for quality improvement activities and performance improvement projects. 2) Continuous quality assessment and probing to promote tangible and required performance improvement. 3) Targeted efforts to minimize encountered barriers that impede full continuum of care, in order to drive improved healthcare outcomes for our population. 4) Maintain partnerships with stakeholders that will maximize the plan’s capability to provide adequate healthcare services and benefits.
Pharmacy and Therapeutic Committee (P&T) to be covered only through an exception process if certain clinical criteria are met. ● An exception request may be used for (i) Non-FMC drugs, or (ii) medications covered with utilization management edits under the FMC (such as step therapy, quantity or dose limits, or prior authorization requirements), when the prescriber wishes to bypass such restrictions. In those cases, MMM Multi Health must suggest that the prescriber first consider using drugs listed on the List of Medications by Exception (LME). If the prescriber demonstrates that none of the alternatives in the LME are clinically viable for the patient, then MMM Multi Health can consider approving coverage for drugs outside of the LME. ● If a drug outside of the FMC but inside the LME is prescribed, the drug will be managed as an exception request. All evaluations will have to evidence medical necessity and will have to be justified by the patients prescribing physician. o Prescribing physician will have to evidence contraindication for all for the alternatives within the FMC. The MCO will request a copy of the patient’s medical history that validates the presented contraindication to all the FMC alternatives or physician should provide scientific evidence that substantiates that the utilization of one of the FMC alternatives would represent serious health repercussion to the patients’ health. o Patient has experienced serious adverse reactions to all the alternatives of the FMC. o Patient has failed experienced therapeutic failure to all the alternatives in the FMC due to ineffectiveness of therapy or because it has severely worsen the patient’s condition or illness. ● If a drug outside of the FMC and the LME is prescribed, the drug will be managed as an exception request. All evaluations will have to evidence
Listed below are the services that Vital Plan covers. Some services may have limits. Call your Insurer at 1-844-336-3331 (toll free), TTY 787-999-4411 (for the hearing impaired) if you want more information. Routine doctor office visits, checkups, and sick visits. Well-baby visits, well-child visits, and immunizations.
This way, you only have to pay for the medicine once instead of paying three times (1 payment per month).
If you need help finding mental health, alcohol and substance abuse services, call your Insurer at 1-844-336-3331 (toll free), TTY 787-999-4411 (for the hearing impaired).
The Puerto Rico Department of Health charges a nominal fee up to $5.00 for the emission of the certificate.
Vital Plan offers services to keep you healthy. Vital Plan works with Insurers, who coordinate with you and your doctors to help you access services you need. You can start getting services as soon as your Medicaid Office tells that you are eligible for the Government Health Program. You don’t have to wait.
Any applicable copayment for procedures or laboratories for the emission of a Health Certificate will be the sole responsibility of the beneficiary.
Vital Plan offers mental health, alcohol and substances abuse services. You do not have to see your PCP first to see a doctor or other provider for mental health, alcohol or substances abuse services. You can ask for these services whenever you feel like you need them.